Bromodomain-containing protein 7 sensitizes breast cancer cells to paclitaxel by activating Bcl2-antagonist/killer protein

Our previous study demonstrated that bromodomain-containing protein 7 (BRD7) inhibits cell proliferation and tumor growth, restoring the expression of B-cell lymphoma 2 antagonist/killer (Bak) sensitized breast cancer cells to paclitaxel. However, the association between BRD7 and paclitaxel sensitiz...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jinqi, Niu, Weihong, Wang, Xinye, Zhou, Yao, Wang, Heran, Liu, Fengxia, Liu, Yukun, Guo, Jie, Xiong, Wei, Zeng, Zhaoyang, Fan, Songqing, Li, Xiaoling, Nie, Xinmin, Li, Guiyuan, Gui, Rong, Luo, Yanwei, Zhou, Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365691/
https://www.ncbi.nlm.nih.gov/pubmed/30592293
http://dx.doi.org/10.3892/or.2018.6951

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365691/
https://www.ncbi.nlm.nih.gov/pubmed/30592293
http://dx.doi.org/10.3892/or.2018.6951

Ejemplares similares